Psychosocial Factors and Quality of Life in the Effect of Fear of COVID-19 With Cystic Fibrosis

Completed

• Conditions: Cystic Fibrosis
• Interventions: Behavioral: Survey Form, The Hospital Anxiety and Depression Scale, The Fear of COVID-19 Scale,World Health Organization Quality of Life Scale- Bref Form

• Registration Number: NCT05195216
• Lead Sponsor: Elif Kabasakal

Brief Summary

The purpose of this study; The COVID-19 pandemic is to investigate the effects of COVID-19 fear levels of patients with cystic fibrosis on the psychosocial and quality of life levels of individuals.

Detailed Description

After individuals were informed about the study, it was administered to individuals who gave written informed consent.This study was carried out on individuals with cystic fibrosis and healthy individuals who meet the eligibility requirements, through online forms.

Study Timeline

• Study Start: 2021-11-20
• Primary Completion: 2021-11-30
• Study Completion: 2021-12-25
• Status Verified: 2022-01
• Study First Submitted: 2022-01-13
• Study First Submitted QC: 2022-01-13
• Last Update Submitted: 2022-01-13
• Study First Posted: 2022-01-18
• Last Update Posted: 2022-01-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 128

Inclusion Criteria

• be 16 years of age or older
• Having been diagnosed with Cystic Fibrosis
• Volunteering to participate in the research

Exclusion Criteria

• Being mentally incapable of successfully applying the scales to be applied for evaluation purposes
• Being treated with sedative and antiepileptic drugs
• Pregnancy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
healthy individuals	Survey Form, The Hospital Anxiety and Depression Scale, The Fear of COVID-19 Scale,World Health Organization Quality of Life Scale- Bref Form	-
individuals with cystic fibrosis	Survey Form, The Hospital Anxiety and Depression Scale, The Fear of COVID-19 Scale,World Health Organization Quality of Life Scale- Bref Form	-

Primary Outcome Measures

Name	Time	Method
fear of covid-19	November- December/2021	COVID-19 Fear Scale: This scale is a one-dimensional instrument consisting of seven items with robust psychometric properties that measure fear of COVID-19. It has a 5-point Likert-type rating system (1: Strongly disagree, 5: Strongly agree). It is reliable and valid in assessing fear of COVID-19 among the general population. Turkish validity and reliability of the scale were ensured.

Secondary Outcome Measures

Name	Time	Method
psychosocial factors	November-December/2021November-December/2021	Hospital Anxiety and Depression Scale (HADS): The scale consists of 14 items. 7 of these items measure anxiety and 7 of them measure depression symptoms. The items in the scale are evaluated with a 4-point Likert scale and are based on a scoring system between 0-3.

Trial Locations

Locations (1)

Elif Kabasakal; 🇹🇷 Istanbul, İ̇stanbul, Turkey